Cerebramin - brain bioregulator.

Pathology of the central nervous system most often develops after trauma, infections, autoimmune, cardiovascular and metabolic diseases, and accompanied by a significant decline in the quality of life of patients. Polymorphism of clinical and morphological manifestations of brain pathology is largely due to the peculiarities of the neurophysiological changes at different levels of integrative activity of the brain, which in turn depend on the genotype and phenotypic susceptibility to diseases of the brain. All reactions that occur after cerebral lesions, considered as a set of pathological and compensatory-adaptive processes that take place at regular intervals. Etiopathogenic factors contributing to the development of diseases of cerebral structures are diverse, so for the correction and prevention of disorders of the brain, occurring in various diseases, developed "Cerebramin®" 

• Has a selective effect on brain cells and normalizes its function, improves memory and attention provided to prevent possible violations of cerebral circulation and their effects.
• Accelerates functional recovery of the brain after traumatic brain injury, stroke, surgery on the brain, with cerebral palsy, learning disabilities, delayed psychomotor and speech development in children, intellectual-mental disorders. 
• It is recommended for intense mental activity, as well as for the elderly to maintain the functions of the brain. 

Dosage:

1-3 tablets 2-3 times a day for 10-15 minutes before meals with water without chewing. Rate: 10-14 days. Repeat the course in 3-6 months. 

Contraindications:

individual intolerance to the components, pregnancy, breast-feeding.

Form of release:

40 tablets per pack